Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

NASDAQ:LNTH

Overview | Financials
Company Name Lantheus Holdings, Inc.
Symbol LNTH
Currency USD
Price 81.49
Market Cap 5,637,950,842
Dividend Yield 0%
52-week-range 73.11 - 126.89
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Mary Anne Heino
Website https://www.lantheus.com

An error occurred while fetching data.

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to

Related Stocks

Premier, Inc. logo

Premier, Inc.

PINC

21.61 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

310.69 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

153.35 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

17.43 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

18.94 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

131.82 USD

Alkermes plc logo

Alkermes plc

ALKS

28.81 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

28.87 USD

Financials

Numbers are in millions USD

Numbers are in millions USD